Medite Cancer Diagnostics Inc (MDIT)

[utterbull]

Just to rephrase my point: the stigma of a RS is based on statistics that suggest its not good. However no one is looking at cycr as a unique case. As I said before there is no threat of being delisted, it's only fall from grace is that trials have not been completed according to some peoples schedule and apparently they have little debt to speak of. Fundamentally nothing has changed.

FWIW im holding my position, I don't like the idea that a PR could be posted after hours describing imminent success realizing that everyone between .30 and $1 will take their sales orders off the table by the morning. Even if it takes a little more time to complete trials.